Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of a single dose of IBIO-600 in overweight or obese adults; status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• IBIO-600

Snippet

Sponsor: iBio, Inc. | Conditions: Overweight , Obesity | Phase 1 | Status: NOT_YET_RECRUITING